25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ChoA Pharmaceutical Co.Ltd
Buy, Hold or Sell?

Let's analyze Choa together

I guess you are interested in ChoA Pharmaceutical Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ChoA Pharmaceutical Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ChoA Pharmaceutical Co.Ltd

I send you an email if I find something interesting about ChoA Pharmaceutical Co.Ltd.

1. Quick Overview

1.1. Quick analysis of Choa (30 sec.)










1.2. What can you expect buying and holding a share of Choa? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩1,146.40
Expected worth in 1 year
₩659.81
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
₩-486.59
Return On Investment
-48.5%

For what price can you sell your share?

Current Price per Share
₩1,003.00
Expected price per share
₩797.00 - ₩1,471
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Choa (5 min.)




Live pricePrice per Share (EOD)
₩1,003.00

2.2. Growth of Choa (5 min.)




Is Choa growing?

Current yearPrevious yearGrowGrow %
How rich?$24.8m$35.5m-$7.6m-27.6%

How much money is Choa making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m$342.9k-$2.5m-115.2%
Net Profit Margin-20.9%2.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Choa (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Choa?

Welcome investor! Choa's management wants to use your money to grow the business. In return you get a share of Choa.

First you should know what it really means to hold a share of Choa. And how you can make/lose money.

Speculation

The Price per Share of Choa is ₩1,003. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Choa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Choa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩1,146.40. Based on the TTM, the Book Value Change Per Share is ₩-121.65 per quarter. Based on the YOY, the Book Value Change Per Share is ₩20.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Choa.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.030.0%-0.070.0%0.000.0%-0.030.0%-0.010.0%
Usd Book Value Change Per Share-0.040.0%-0.090.0%0.010.0%-0.020.0%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.040.0%-0.090.0%0.010.0%-0.020.0%-0.010.0%
Usd Price Per Share1.05-1.29-1.58-2.26-2.79-
Price to Earnings Ratio-8.04--6.42-84.80-14.65-149.42-
Price-to-Total Gains Ratio-29.42--23.39-45.26-99.98--31.90-
Price to Book Ratio1.31-1.44-1.37-1.93-2.46-
Price-to-Total Gains Ratio-29.42--23.39-45.26-99.98--31.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7021
Number of shares1424
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.02
Usd Total Gains Per Share-0.09-0.02
Gains per Quarter (1424 shares)-121.26-28.66
Gains per Year (1424 shares)-485.03-114.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-485-4950-115-125
20-970-9800-229-240
30-1455-14650-344-355
40-1940-19500-459-470
50-2425-24350-573-585
60-2910-29200-688-700
70-3395-34050-802-815
80-3880-38900-917-930
90-4365-43750-1032-1045
100-4850-48600-1146-1160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%20.016.04.050.0%23.016.07.050.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%20.020.00.050.0%24.022.00.052.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%20.020.00.050.0%24.022.00.052.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ChoA Pharmaceutical Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---50.978-121.647+139%20.746-346%-28.752-44%-10.950-79%
Book Value Per Share--1146.3971284.873-11%1639.499-30%1635.227-30%1612.148-29%
Current Ratio--1.3581.478-8%1.799-25%2.012-33%1.610-16%
Debt To Asset Ratio--0.5330.480+11%0.389+37%0.386+38%0.377+41%
Debt To Equity Ratio--1.0660.888+20%0.626+70%0.634+68%0.604+76%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--5936947500.00020518409479.750-71%41308780900.000-86%76015504588.450-92%97242663104.475-94%
Eps---46.618-104.011+123%-2.518-95%-41.898-10%-17.422-63%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.0970.337-71%0.605-84%1.207-92%1.658-94%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Market Cap31072739400.000-50%46469740500.00057134545944.750-19%69743339010.000-33%100168587453.450-54%123732617739.225-62%
Net Profit Margin---0.094-0.209+121%0.024-488%-0.079-16%-0.032-66%
Operating Margin----0%-0.0030%-0.0300%-0.0100%
Operating Ratio--1.3051.692-23%1.126+16%0.987+32%0.975+34%
Pb Ratio0.875-50%1.3081.439-9%1.374-5%1.935-32%2.459-47%
Pe Ratio-5.379+33%-8.044-6.422-20%84.800-109%14.651-155%149.421-105%
Price Per Share1003.000-50%1500.0001844.250-19%2251.250-33%3233.350-54%3985.300-62%
Price To Free Cash Flow Ratio----15.1110%7.434-100%-80.4600%8.596-100%
Price To Total Gains Ratio-19.675+33%-29.425-23.385-21%45.260-165%99.980-129%-31.896+8%
Quick Ratio---0.577-100%1.201-100%1.439-100%1.296-100%
Return On Assets---0.019-0.043+124%0.006-435%-0.015-20%-0.006-68%
Return On Equity---0.038-0.077+103%0.009-509%-0.026-32%-0.011-72%
Total Gains Per Share---50.978-121.647+139%20.746-346%-28.752-44%-10.950-79%
Usd Book Value--24860633.70027863603.856-11%35553983.194-30%35461331.026-30%35025659.187-29%
Usd Book Value Change Per Share---0.036-0.085+139%0.015-346%-0.020-44%-0.008-79%
Usd Book Value Per Share--0.8020.899-11%1.148-30%1.145-30%1.129-29%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--4155863.25014362886.636-71%28916146.630-86%53210853.212-92%68069864.173-94%
Usd Eps---0.033-0.073+123%-0.002-95%-0.029-10%-0.012-63%
Usd Free Cash Flow----613429.9920%-481526.2410%-593248.6930%-497002.3560%
Usd Market Cap21750917.580-50%32528818.35039994182.161-19%48820337.307-33%70118011.217-54%86612832.417-62%
Usd Price Per Share0.702-50%1.0501.291-19%1.576-33%2.263-54%2.790-62%
Usd Profit---1010956.100-2255573.320+123%342937.476-395%-829092.275-18%-336951.084-67%
Usd Revenue--10718845.20010680539.251+0%11937304.078-10%11201046.066-4%10554240.342+2%
Usd Total Gains Per Share---0.036-0.085+139%0.015-346%-0.020-44%-0.008-79%
 EOD+3 -4MRQTTM+15 -14YOY+4 -265Y+3 -2610Y+7 -24

3.3 Fundamental Score

Let's check the fundamental score of ChoA Pharmaceutical Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.379
Price to Book Ratio (EOD)Between0-10.875
Net Profit Margin (MRQ)Greater than0-0.094
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.358
Debt to Asset Ratio (MRQ)Less than10.533
Debt to Equity Ratio (MRQ)Less than11.066
Return on Equity (MRQ)Greater than0.15-0.038
Return on Assets (MRQ)Greater than0.05-0.019
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of ChoA Pharmaceutical Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.299
Ma 20Greater thanMa 50917.950
Ma 50Greater thanMa 1001,119.520
Ma 100Greater thanMa 2001,291.160
OpenGreater thanClose912.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About ChoA Pharmaceutical Co.Ltd

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets. It also provides medicine supply and pharmacy management services. The company exports its products to approximately 20 countries worldwide. The company was founded in 1964 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 14:48:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Choa earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -9.4% means that ₩-0.09 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is -9.4%. The company is making a loss. -1
  • The TTM is -20.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-20.9%+11.4%
TTM-20.9%YOY2.4%-23.3%
TTM-20.9%5Y-7.9%-13.0%
5Y-7.9%10Y-3.2%-4.7%
4.3.1.2. Return on Assets

Shows how efficient Choa is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.9% Return on Assets means that Choa generated ₩-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is -1.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM-4.3%+2.4%
TTM-4.3%YOY0.6%-4.8%
TTM-4.3%5Y-1.5%-2.8%
5Y-1.5%10Y-0.6%-0.9%
4.3.1.3. Return on Equity

Shows how efficient Choa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.8% Return on Equity means Choa generated ₩-0.04 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is -3.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.8%TTM-7.7%+3.9%
TTM-7.7%YOY0.9%-8.6%
TTM-7.7%5Y-2.6%-5.1%
5Y-2.6%10Y-1.1%-1.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ChoA Pharmaceutical Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Choa is operating .

  • Measures how much profit Choa makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.3%+0.3%
TTM-5Y-3.0%+3.0%
5Y-3.0%10Y-1.0%-2.0%
4.3.2.2. Operating Ratio

Measures how efficient Choa is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are ₩1.30 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 1.305. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.692. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.305TTM1.692-0.387
TTM1.692YOY1.126+0.566
TTM1.6925Y0.987+0.705
5Y0.98710Y0.975+0.012
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ChoA Pharmaceutical Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Choa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.36 means the company has ₩1.36 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 1.358. The company is just able to pay all its short-term debts.
  • The TTM is 1.478. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.358TTM1.478-0.120
TTM1.478YOY1.799-0.321
TTM1.4785Y2.012-0.534
5Y2.01210Y1.610+0.402
4.4.3.2. Quick Ratio

Measures if Choa is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.577-0.577
TTM0.577YOY1.201-0.624
TTM0.5775Y1.439-0.862
5Y1.43910Y1.296+0.144
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ChoA Pharmaceutical Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Choa assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Choa to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Choa assets are financed with 53.3% credit (debt) and the remaining percentage (100% - 53.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 0.533. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.480. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.533TTM0.480+0.053
TTM0.480YOY0.389+0.092
TTM0.4805Y0.386+0.094
5Y0.38610Y0.377+0.009
4.5.4.2. Debt to Equity Ratio

Measures if Choa is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 106.6% means that company has ₩1.07 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 1.066. The company is able to pay all its debts with equity. +1
  • The TTM is 0.888. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.066TTM0.888+0.178
TTM0.888YOY0.626+0.262
TTM0.8885Y0.634+0.253
5Y0.63410Y0.604+0.030
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Choa generates.

  • Above 15 is considered overpriced but always compare Choa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -8.04 means the investor is paying ₩-8.04 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The EOD is -5.379. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.044. Based on the earnings, the company is expensive. -2
  • The TTM is -6.422. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.379MRQ-8.044+2.665
MRQ-8.044TTM-6.422-1.622
TTM-6.422YOY84.800-91.221
TTM-6.4225Y14.651-21.072
5Y14.65110Y149.421-134.770
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-15.111+15.111
TTM-15.111YOY7.434-22.545
TTM-15.1115Y-80.460+65.348
5Y-80.46010Y8.596-89.055
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Choa is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.31 means the investor is paying ₩1.31 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of ChoA Pharmaceutical Co.Ltd:

  • The EOD is 0.875. Based on the equity, the company is cheap. +2
  • The MRQ is 1.308. Based on the equity, the company is underpriced. +1
  • The TTM is 1.439. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.875MRQ1.308-0.434
MRQ1.308TTM1.439-0.130
TTM1.439YOY1.374+0.065
TTM1.4395Y1.935-0.496
5Y1.93510Y2.459-0.525
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -595,413-1,996,730-2,592,142-851,826-3,443,9681,714,399-1,729,5697,053,4265,323,857



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets76,047,984
Total Liabilities40,532,793
Total Stockholder Equity38,022,714
 As reported
Total Liabilities 40,532,793
Total Stockholder Equity+ 38,022,714
Total Assets = 76,047,984

Assets

Total Assets76,047,984
Total Current Assets44,429,108
Long-term Assets31,618,876
Total Current Assets
Total Current Assets  (as reported)44,429,108
Total Current Assets  (calculated)0
+/- 44,429,108
Long-term Assets
Long-term Assets  (as reported)31,618,876
Long-term Assets  (calculated)0
+/- 31,618,876

Liabilities & Shareholders' Equity

Total Current Liabilities32,726,140
Long-term Liabilities7,806,653
Total Stockholder Equity38,022,714
Total Current Liabilities
Total Current Liabilities  (as reported)32,726,140
Total Current Liabilities  (calculated)0
+/- 32,726,140
Long-term Liabilities
Long-term Liabilities  (as reported)7,806,653
Long-term Liabilities  (calculated)0
+/- 7,806,653
Total Stockholder Equity
Total Stockholder Equity (as reported)38,022,714
Total Stockholder Equity (calculated)0
+/- 38,022,714
Other
Common Stock Shares Outstanding 30,980
Net Invested Capital 38,022,714
Net Working Capital 11,702,968



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
66,759,285
66,542,607
68,237,301
70,815,020
70,804,948
74,702,065
74,787,960
74,046,793
74,524,970
74,718,279
75,534,654
74,347,704
73,871,640
75,800,060
74,838,539
75,097,367
73,725,347
74,897,985
76,008,401
83,518,178
82,798,731
84,751,136
85,298,712
84,040,798
84,259,816
87,954,811
86,984,744
86,742,091
86,048,182
85,907,286
86,353,163
82,376,967
83,937,704
84,086,937
85,041,372
80,512,093
78,981,529
79,993,264
80,964,014
85,639,409
83,286,726
82,290,391
79,470,821
74,221,475
75,944,859
76,047,984
76,047,98475,944,85974,221,47579,470,82182,290,39183,286,72685,639,40980,964,01479,993,26478,981,52980,512,09385,041,37284,086,93783,937,70482,376,96786,353,16385,907,28686,048,18286,742,09186,984,74487,954,81184,259,81684,040,79885,298,71284,751,13682,798,73183,518,17876,008,40174,897,98573,725,34775,097,36774,838,53975,800,06073,871,64074,347,70475,534,65474,718,27974,524,97074,046,79374,787,96074,702,06570,804,94870,815,02068,237,30166,542,60766,759,285
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43,552,225
44,875,178
52,746,012
52,183,948
53,529,447
53,247,885
53,438,139
53,890,351
56,339,486
55,468,500
53,801,503
51,696,222
50,880,724
51,343,714
47,349,631
48,585,950
48,773,756
50,131,142
46,504,081
44,820,325
46,065,506
45,800,203
48,199,874
46,141,598
45,991,696
43,897,072
42,156,851
44,319,123
44,429,108
44,429,10844,319,12342,156,85143,897,07245,991,69646,141,59848,199,87445,800,20346,065,50644,820,32546,504,08150,131,14248,773,75648,585,95047,349,63151,343,71450,880,72451,696,22253,801,50355,468,50056,339,48653,890,35153,438,13953,247,88553,529,44752,183,94852,746,01244,875,17843,552,22500000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,622,923
3,409,372
10,578,963
9,939,199
11,908,035
10,301,188
10,137,143
9,975,618
11,015,450
10,885,495
10,015,493
8,439,384
5,335,415
5,542,372
4,154,574
4,413,899
5,405,846
7,204,202
19,130
0
0
0
27,185
3,622,372
3,139,500
1,927,855
2,047,224
5,938,575
0
05,938,5752,047,2241,927,8553,139,5003,622,37227,18500019,1307,204,2025,405,8464,413,8994,154,5745,542,3725,335,4158,439,38410,015,49310,885,49511,015,4509,975,61810,137,14310,301,18811,908,0359,939,19910,578,9633,409,3721,622,92300000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,844,501
1,604,501
1,644,912
1,644,912
1,649,912
1,649,912
1,820,387
1,820,387
1,880,387
1,530,387
0
0
0
5,082,134
4,901,028
5,892,884
6,195,446
6,076,165
4,465,164
4,445,854
4,145,421
3,911,267
2,470,295
3,386,974
2,915,502
2,865,163
2,313,307
898,383
0
0898,3832,313,3072,865,1632,915,5023,386,9742,470,2953,911,2674,145,4214,445,8544,465,1646,076,1656,195,4465,892,8844,901,0285,082,1340001,530,3871,880,3871,820,3871,820,3871,649,9121,649,9121,644,9121,644,9121,604,5011,844,50100000000000000000
       Net Receivables 
18,791,514
18,622,918
19,274,471
22,266,021
18,872,324
18,736,311
18,461,519
20,609,265
18,146,934
19,323,729
19,163,143
21,737,588
20,013,527
19,713,773
20,436,944
24,294,196
21,695,245
22,310,333
25,678,503
26,212,076
25,772,616
27,501,862
27,839,692
28,431,288
0
29,629,154
23,130,434
28,094,551
27,777,800
27,690,187
27,216,318
25,038,624
25,034,154
25,001,691
24,882,266
19,509,893
19,675,950
26,105,131
25,874,411
21,918,956
26,889,582
21,557,977
20,344,591
20,230,026
19,125,021
0
019,125,02120,230,02620,344,59121,557,97726,889,58221,918,95625,874,41126,105,13119,675,95019,509,89324,882,26625,001,69125,034,15425,038,62427,216,31827,690,18727,777,80028,094,55123,130,43429,629,154028,431,28827,839,69227,501,86225,772,61626,212,07625,678,50322,310,33321,695,24524,294,19620,436,94419,713,77320,013,52721,737,58819,163,14319,323,72918,146,93420,609,26518,461,51918,736,31118,872,32422,266,02119,274,47118,622,91818,791,514
       Other Current Assets 
6,267,527
6,859,559
6,800,472
1,486,775
5,332,946
7,149,254
6,131,497
1,104,859
6,383,506
7,608,914
7,293,259
1,335,122
5,948,345
7,085,848
6,399,206
3,699,625
6,117,686
6,072,659
534,598
425,992
861,111
736,614
1,181,513
977,315
30,074,677
1,150,362
1,631,625
1,083,690
29,539,710
1,778,053
1,636,897
597,901
926,538
1,488,881
1,689,386
601,287
1,074,183
849,857
974,473
1,950,617
1,009,722
487,689
835,628
-1
766,924
0
0766,924-1835,628487,6891,009,7221,950,617974,473849,8571,074,183601,2871,689,3861,488,881926,538597,9011,636,8971,778,05329,539,7101,083,6901,631,6251,150,36230,074,677977,3151,181,513736,614861,111425,992534,5986,072,6596,117,6863,699,6256,399,2067,085,8485,948,3451,335,1227,293,2597,608,9146,383,5061,104,8596,131,4977,149,2545,332,9461,486,7756,800,4726,859,5596,267,527
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,439,535
37,145,127
36,298,695
35,573,749
32,064,625
31,625,735
31,618,876
31,618,87631,625,73532,064,62535,573,74936,298,69537,145,12737,439,535000000000000000000000000000000000000000
       Property Plant Equipment 
15,988,355
15,797,278
15,705,667
15,824,898
16,480,715
20,157,757
20,238,490
20,137,441
20,484,725
20,710,465
20,655,188
20,499,352
20,571,659
20,912,568
21,119,697
21,481,908
20,952,968
20,490,784
20,122,244
19,940,388
19,674,596
19,545,510
20,028,355
20,001,916
19,727,450
20,580,605
20,344,936
21,547,572
22,340,676
22,715,334
22,519,904
22,190,191
23,985,346
24,362,398
25,083,194
24,074,026
24,225,881
24,586,773
24,757,541
24,999,249
25,008,414
24,650,735
24,224,710
20,369,879
20,040,849
0
020,040,84920,369,87924,224,71024,650,73525,008,41424,999,24924,757,54124,586,77324,225,88124,074,02625,083,19424,362,39823,985,34622,190,19122,519,90422,715,33422,340,67621,547,57220,344,93620,580,60519,727,45020,001,91620,028,35519,545,51019,674,59619,940,38820,122,24420,490,78420,952,96821,481,90821,119,69720,912,56820,571,65920,499,35220,655,18820,710,46520,484,72520,137,44120,238,49020,157,75716,480,71515,824,89815,705,66715,797,27815,988,355
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,775
0
0
0
46,775
0
0
0
0
0
0
0
0
0
0
000000000046,77500046,7750000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,083,904
1,228,484
1,244,132
1,406,810
1,566,845
1,859,308
1,857,833
2,025,787
2,188,721
2,373,512
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,373,5122,188,7212,025,7871,857,8331,859,3081,566,8451,406,8101,244,1321,228,4841,083,90400000000000000000
       Intangible Assets 
547,076
507,346
501,926
458,439
414,385
394,238
357,613
385,610
362,594
343,178
311,600
268,474
242,310
214,012
475,776
480,673
462,019
436,176
414,772
395,494
418,398
397,502
463,506
443,157
518,414
602,258
580,476
637,328
692,849
677,280
652,145
583,499
650,932
802,905
780,440
795,501
881,970
878,046
843,372
806,870
810,796
771,719
769,664
803,404
814,190
0
0814,190803,404769,664771,719810,796806,870843,372878,046881,970795,501780,440802,905650,932583,499652,145677,280692,849637,328580,476602,258518,414443,157463,506397,502418,398395,494414,772436,176462,019480,673475,776214,012242,310268,474311,600343,178362,594385,610357,613394,238414,385458,439501,926507,346547,076
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
1,877,894
1,613,601
14,208
-1
12,833
0
012,833-114,2081,613,6011,877,894-1000000000000000000000000000000000000000
> Total Liabilities 
18,319,806
17,684,345
18,691,436
20,188,967
20,709,177
25,617,233
26,207,714
27,956,919
28,311,520
28,395,466
28,870,005
27,193,142
26,641,261
28,587,231
27,499,581
28,032,722
27,090,766
27,609,313
28,355,670
30,333,305
29,242,937
29,773,375
29,650,018
31,131,670
31,028,746
34,625,167
33,211,268
33,686,011
32,932,847
26,299,809
26,544,330
24,074,927
26,779,663
28,616,269
31,227,885
30,591,706
30,231,503
31,974,438
32,702,249
32,795,585
31,816,292
31,700,796
31,617,759
35,463,610
38,850,384
40,532,793
40,532,79338,850,38435,463,61031,617,75931,700,79631,816,29232,795,58532,702,24931,974,43830,231,50330,591,70631,227,88528,616,26926,779,66324,074,92726,544,33026,299,80932,932,84733,686,01133,211,26834,625,16731,028,74631,131,67029,650,01829,773,37529,242,93730,333,30528,355,67027,609,31327,090,76628,032,72227,499,58128,587,23126,641,26127,193,14228,870,00528,395,46628,311,52027,956,91926,207,71425,617,23320,709,17720,188,96718,691,43617,684,34518,319,806
   > Total Current Liabilities 
11,925,229
11,178,054
9,960,388
10,825,213
11,686,060
18,503,736
18,750,659
19,319,337
19,589,503
17,832,504
18,134,698
20,854,014
19,675,296
24,043,042
23,116,149
24,069,954
21,442,460
21,696,933
22,169,967
16,497,446
13,890,913
17,072,288
16,433,218
24,327,774
24,039,754
23,923,878
23,595,639
23,382,434
22,323,755
19,441,643
19,473,529
19,178,102
20,028,407
21,435,642
23,961,209
24,262,548
23,645,179
25,195,990
25,699,230
27,327,776
24,754,847
25,756,051
25,791,469
29,177,888
31,484,240
32,726,140
32,726,14031,484,24029,177,88825,791,46925,756,05124,754,84727,327,77625,699,23025,195,99023,645,17924,262,54823,961,20921,435,64220,028,40719,178,10219,473,52919,441,64322,323,75523,382,43423,595,63923,923,87824,039,75424,327,77416,433,21817,072,28813,890,91316,497,44622,169,96721,696,93321,442,46024,069,95423,116,14924,043,04219,675,29620,854,01418,134,69817,832,50419,589,50319,319,33718,750,65918,503,73611,686,06010,825,2139,960,38811,178,05411,925,229
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,934,473
2,000,000
16,667,105
15,840,166
2,000,000
2,000,000
9,859,214
2,000,000
8,376,586
8,649,086
3,450,000
0
4,450,000
4,450,000
4,450,000
7,150,000
10,127,500
12,694,011
12,794,011
13,176,289
13,458,281
13,408,281
14,553,829
0
0
0
0
0
0
00000014,553,82913,408,28113,458,28113,176,28912,794,01112,694,01110,127,5007,150,0004,450,0004,450,0004,450,00003,450,0008,649,0868,376,5862,000,0009,859,2142,000,0002,000,00015,840,16616,667,1052,000,00012,934,47300000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,934,473
2,000,000
16,667,105
15,840,166
2,000,000
2,000,000
9,859,214
2,000,000
8,376,586
0
0
0
0
0
0
0
0
0
0
0
0
0
14,553,829
14,795,411
14,598,945
14,548,945
14,550,000
18,838,651
0
018,838,65114,550,00014,548,94514,598,94514,795,41114,553,82900000000000008,376,5862,000,0009,859,2142,000,0002,000,00015,840,16616,667,1052,000,00012,934,47300000000000000000
       Accounts payable 
1,203,785
1,427,621
1,470,721
1,768,821
1,937,327
1,677,160
1,463,139
1,721,993
2,062,280
2,126,503
2,089,705
1,828,589
1,888,937
1,938,895
2,055,843
2,619,347
3,028,549
2,886,070
3,000,621
2,651,843
3,123,452
3,157,404
2,613,519
2,437,231
2,986,028
3,741,826
3,566,248
3,497,774
3,529,368
4,168,090
4,046,763
3,598,765
3,533,638
3,573,626
3,592,391
0
0
4,203,278
4,445,924
4,994,159
3,039,408
3,951,181
4,137,963
5,500,678
5,127,369
0
05,127,3695,500,6784,137,9633,951,1813,039,4084,994,1594,445,9244,203,278003,592,3913,573,6263,533,6383,598,7654,046,7634,168,0903,529,3683,497,7743,566,2483,741,8262,986,0282,437,2312,613,5193,157,4043,123,4522,651,8433,000,6212,886,0703,028,5492,619,3472,055,8431,938,8951,888,9371,828,5892,089,7052,126,5032,062,2801,721,9931,463,1391,677,1601,937,3271,768,8211,470,7211,427,6211,203,785
       Other Current Liabilities 
3,384,212
3,771,350
3,547,312
4,018,937
3,339,709
3,888,734
4,187,433
4,393,656
3,828,567
4,767,810
4,656,739
7,340,873
6,068,383
8,064,657
7,587,406
8,233,175
5,369,479
5,876,390
5,633,181
6,095,603
5,067,461
5,263,884
5,219,699
4,024,179
5,441,069
6,951,796
6,577,287
4,708,103
9,348,417
6,292,864
6,505,327
4,019,767
5,848,992
6,745,934
6,793,624
0
0
6,804,755
7,212,028
1
6,195,896
2,959,494
2,997,230
0
777,371
0
0777,37102,997,2302,959,4946,195,89617,212,0286,804,755006,793,6246,745,9345,848,9924,019,7676,505,3276,292,8649,348,4174,708,1036,577,2876,951,7965,441,0694,024,1795,219,6995,263,8845,067,4616,095,6035,633,1815,876,3905,369,4798,233,1757,587,4068,064,6576,068,3837,340,8734,656,7394,767,8103,828,5674,393,6564,187,4333,888,7343,339,7094,018,9373,547,3123,771,3503,384,212
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,903,426
7,061,445
5,944,745
5,826,290
6,285,722
7,366,144
7,806,653
7,806,6537,366,1446,285,7225,826,2905,944,7457,061,4456,903,426000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,292,480
5,483,711
5,464,736
1,545,055
1,492,258
1,349,641
2,933,316
2,771,010
2,593,375
2,995,722
2,905,412
2,855,516
2,772,062
3,486,546
0
0
0
0
0
0
0000003,486,5462,772,0622,855,5162,905,4122,995,7222,593,3752,771,0102,933,3161,349,6411,492,2581,545,0555,464,7365,483,7114,292,48000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-12,934,473
-2,000,000
-16,667,105
-15,840,166
-2,000,000
-2,000,000
-9,859,214
-2,000,000
-8,376,586
-8,649,086
-3,450,000
0
-4,450,000
-4,450,000
-4,450,000
-7,150,000
-10,127,500
-12,694,011
-12,794,011
-13,176,289
-13,458,281
-13,408,281
-12,333,283
2,280,386
2,123,942
1,959,488
1,846,127
1,849,274
0
01,849,2741,846,1271,959,4882,123,9422,280,386-12,333,283-13,408,281-13,458,281-13,176,289-12,794,011-12,694,011-10,127,500-7,150,000-4,450,000-4,450,000-4,450,0000-3,450,000-8,649,086-8,376,586-2,000,000-9,859,214-2,000,000-2,000,000-15,840,166-16,667,105-2,000,000-12,934,47300000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
667,704
688,090
0
0
2,701,265
0
02,701,26500688,090667,7040000000000000000000000000000000000000000
> Total Stockholder Equity
48,948,711
49,364,378
50,091,916
51,183,830
50,654,706
49,630,499
49,139,813
46,716,172
46,842,551
46,949,115
47,295,551
47,857,941
47,995,763
48,009,170
48,149,562
47,839,373
47,474,461
48,152,889
48,563,079
54,175,918
54,552,241
55,996,738
56,688,462
53,964,789
54,307,572
54,459,170
53,773,476
53,056,080
53,115,335
59,607,477
59,808,834
58,302,040
57,158,041
55,470,668
53,813,486
49,920,386
48,750,026
48,018,826
48,261,765
52,843,824
53,066,032
52,305,197
49,753,533
40,993,085
39,466,693
38,022,714
38,022,71439,466,69340,993,08549,753,53352,305,19753,066,03252,843,82448,261,76548,018,82648,750,02649,920,38653,813,48655,470,66857,158,04158,302,04059,808,83459,607,47753,115,33553,056,08053,773,47654,459,17054,307,57253,964,78956,688,46255,996,73854,552,24154,175,91848,563,07948,152,88947,474,46147,839,37348,149,56248,009,17047,995,76347,857,94147,295,55146,949,11546,842,55146,716,17249,139,81349,630,49950,654,70651,183,83050,091,91649,364,37848,948,711
   Common Stock
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,155,116
14,384,225
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
15,489,914
0
0
0
0
0
0000015,489,91415,489,91415,489,91415,489,91415,489,91415,489,91415,489,91415,489,91415,489,91415,489,91415,489,91415,489,91414,384,22514,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,11614,155,116
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,456,583
53,456,583
55,084,239
62,649,115
62,649,115
62,041,774
62,041,774
62,041,774
62,041,774
62,041,774
62,041,774
62,041,774
62,041,774
62,041,774
0
0
0
0
0
0
00000062,041,77462,041,77462,041,77462,041,77462,041,77462,041,77462,041,77462,041,77462,041,77462,649,11562,649,11555,084,23953,456,58353,456,58300000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
328
1,270,244
-595
0
0
0
0
-1
0
4,909,573
372,069
372,068
373,713
-3,447,363
-50,281
-21,933
-20,459
62,514
1,643,410
1,643,410
159,437
285,263
1,665,650
139,654
0
0
0
0
0
00000139,6541,665,650285,263159,4371,643,4101,643,41062,514-20,459-21,933-50,281-3,447,363373,713372,068372,0694,909,5730-10000-5951,270,24432800000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue62,973,743
Cost of Revenue-39,213,050
Gross Profit23,760,69323,760,693
 
Operating Income (+$)
Gross Profit23,760,693
Operating Expense-69,808,721
Operating Income-6,834,978-46,048,028
 
Operating Expense (+$)
Research Development2,182,069
Selling General Administrative9,472,009
Selling And Marketing Expenses0
Operating Expense69,808,72111,654,078
 
Net Interest Income (+$)
Interest Income246,845
Interest Expense-979,329
Other Finance Cost-1
Net Interest Income-732,485
 
Pretax Income (+$)
Operating Income-6,834,978
Net Interest Income-732,485
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,934,163-6,834,978
EBIT - interestExpense = -979,329
-10,514,369
-9,535,040
Interest Expense979,329
Earnings Before Interest and Taxes (EBIT)0-9,954,834
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-10,934,163
Tax Provision-198,699
Net Income From Continuing Ops-11,132,862-11,132,862
Net Income-10,514,369
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0732,485
 

Technical Analysis of Choa
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Choa. The general trend of Choa is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Choa's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ChoA Pharmaceutical Co.Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1,386 < 1,440 < 1,471.

The bearish price targets are: 993.00 > 797.00.

Tweet this
ChoA Pharmaceutical Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ChoA Pharmaceutical Co.Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ChoA Pharmaceutical Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ChoA Pharmaceutical Co.Ltd. The current macd is -51.4984765.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Choa price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Choa. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Choa price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ChoA Pharmaceutical Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChoA Pharmaceutical Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ChoA Pharmaceutical Co.Ltd. The current adx is 56.45.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Choa shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
ChoA Pharmaceutical Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ChoA Pharmaceutical Co.Ltd. The current sar is 800.46.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ChoA Pharmaceutical Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ChoA Pharmaceutical Co.Ltd. The current rsi is 54.30. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
ChoA Pharmaceutical Co.Ltd Daily Relative Strength Index (RSI) ChartChoA Pharmaceutical Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ChoA Pharmaceutical Co.Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Choa price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ChoA Pharmaceutical Co.Ltd Daily Stochastic Oscillator ChartChoA Pharmaceutical Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ChoA Pharmaceutical Co.Ltd. The current cci is 203.26.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
ChoA Pharmaceutical Co.Ltd Daily Commodity Channel Index (CCI) ChartChoA Pharmaceutical Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ChoA Pharmaceutical Co.Ltd. The current cmo is 32.88.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ChoA Pharmaceutical Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartChoA Pharmaceutical Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ChoA Pharmaceutical Co.Ltd. The current willr is -46.21409922.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Choa is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ChoA Pharmaceutical Co.Ltd Daily Williams %R ChartChoA Pharmaceutical Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ChoA Pharmaceutical Co.Ltd.

ChoA Pharmaceutical Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ChoA Pharmaceutical Co.Ltd. The current atr is 62.82.

ChoA Pharmaceutical Co.Ltd Daily Average True Range (ATR) ChartChoA Pharmaceutical Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ChoA Pharmaceutical Co.Ltd. The current obv is 9,737,201.

ChoA Pharmaceutical Co.Ltd Daily On-Balance Volume (OBV) ChartChoA Pharmaceutical Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ChoA Pharmaceutical Co.Ltd. The current mfi is 85.17.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
ChoA Pharmaceutical Co.Ltd Daily Money Flow Index (MFI) ChartChoA Pharmaceutical Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ChoA Pharmaceutical Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

ChoA Pharmaceutical Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ChoA Pharmaceutical Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.299
Ma 20Greater thanMa 50917.950
Ma 50Greater thanMa 1001,119.520
Ma 100Greater thanMa 2001,291.160
OpenGreater thanClose912.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Choa with someone you think should read this too:
  • Are you bullish or bearish on Choa? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Choa? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ChoA Pharmaceutical Co.Ltd

I send you an email if I find something interesting about ChoA Pharmaceutical Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about ChoA Pharmaceutical Co.Ltd.

Receive notifications about ChoA Pharmaceutical Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.